Sandbox:Ascites DD: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
Line 6: Line 6:
|
|
! colspan="5" |Physical Examination
! colspan="5" |Physical Examination
| colspan="4" |Laboratory Findings
| colspan="3" |Laboratory Findings
! rowspan="2" |Other Findings
! rowspan="2" |Other Findings
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
Line 23: Line 23:
* Exudative Vs Transudative
* Exudative Vs Transudative
* Colour  
* Colour  
!Fluid culture
!CBC
!CBC
|-
|-
Line 40: Line 39:
| rowspan="4" style="background: #F5F5F5; padding: 5px;" | ≥1.1
| rowspan="4" style="background: #F5F5F5; padding: 5px;" | ≥1.1
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*
* Opalescent
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 50: Line 50:
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 65: Line 64:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 82: Line 80:
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 105: Line 102:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |<1.1
| style="background: #F5F5F5; padding: 5px;" |<1.1
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 123: Line 119:
| style="background: #F5F5F5; padding: 5px;" | ≥1.1 or <1.1
| style="background: #F5F5F5; padding: 5px;" | ≥1.1 or <1.1
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Exudate
* Turbid or cloudy
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 140: Line 137:
| style="background: #F5F5F5; padding: 5px;" |<1.1
| style="background: #F5F5F5; padding: 5px;" |<1.1
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |Amylase level >100 units/L in the ascitic fluid
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
| rowspan="2" style="background: #F5F5F5; padding: 5px;" |'''Cardiac causes'''
| rowspan="2" style="background: #F5F5F5; padding: 5px;" |'''Cardiac causes'''
Line 157: Line 154:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |≥1.1
| style="background: #F5F5F5; padding: 5px;" |≥1.1
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 174: Line 170:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" | ≥1.1
| style="background: #F5F5F5; padding: 5px;" | ≥1.1
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 192: Line 187:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |<1.1
| style="background: #F5F5F5; padding: 5px;" |<1.1
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 204: Line 198:
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 221: Line 214:
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 244: Line 236:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" | ≥1.1 or <1.1
| style="background: #F5F5F5; padding: 5px;" | ≥1.1 or <1.1
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 251: Line 242:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hypothyroidism
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hypothyroidism
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 278: Line 268:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" | ≥1.1
| style="background: #F5F5F5; padding: 5px;" | ≥1.1
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|}
|}

Revision as of 21:42, 27 November 2017

Preferred Table

Diseases History and Symptoms Physical Examination Laboratory Findings Other Findings
Fever Icterus Abdominal pain Peripheral edema Chest pain Jugular vein distension Hepatomegaly Skin rash Edema Spider angiomata Serum to ascites albumin gradient (SAAG) Ascitic fluid:
  • Exudative Vs Transudative
  • Colour
 CBC
Liver causes Cirrhosis - + - - - + - +  ≥1.1
  • Opalescent
Budd chiari syndrome - + - - -
Acute liver failure + +
Alcoholic hepatitis - - - - -
GI causes Whipple disease + - - - <1.1
Peritonitis + - + - -  ≥1.1 or <1.1
  • Exudate
  • Turbid or cloudy
Pancreatitis + (Severe pancreatitis) - - - - <1.1
Amylase level >100 units/L in the ascitic fluid
Cardiac causes CHF - - - + + ≥1.1
Pericarditis + - - - +  ≥1.1
Renal cause Nephrotic syndrome - - - + - <1.1
Other causes Sarcoidosis + - - - +
SLE + - - - -
TB + - - - +  ≥1.1 or <1.1
Hypothyroidism -
Cancer -  ≥1.1
Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox:Ascites_DD&oldid=1398080"